Polymorphism of metabolizing genes and lung cancer histology

Prevalence of CYP2E1 in adenocarcinoma

Randa A. El-Zein, Joseph B. Zwischenberger, Sherif Abdel-Rahman, Aravind B. Sankar, William W. Au

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

The relationship between genetic predisposition and development of specific cancers has not been adequately elucidated. In this study, the involvement of three polymorphic genes (CYP2E1, GSTM1, and GSTT1) in the development of different histological types of lung cancer was investigated. DNA was extracted from peripheral blood lymphocytes of lung cancer patients who have been long-term cigarette smokers (n = 52). Allelic variants of CYP2E1 were detected using PCR followed by PstI restriction enzyme digest and RFLP analysis, which detects a specific mutation causing over-expression of the gene. GSTM1 and GSTT1 genotypes were detected using two separate differential PCR methods. Our results indicate a 13.5% allele frequency for the CYP2E1 rare PstI site among the lung cancer patients which represents a 3.4-fold increase over the normal controls (OR = 3.5, 95% CL = 0.65-25.8). A novel observation is that all the patients with this polymorphism had adenocarcinomas only, resulting in a significant association between them (OR = 16.17, 95% CL = 0.95-73, P = 0.02). The frequency of the null GSTM1 gene was 42.3% among the lung cancer patients with no preferential tendency towards developing squamous cell carcinoma versus adenocarcinoma (OR = 1.10, 95% CL = 0.3-4.14, P = 0.5). The GSTT1 gene was absent in 21.1% of the patients with a non-significant tendency towards developing squamous cell carcinoma (OR = 1.23, 95% CL = 0.25-6.1, P = 0.5). Another important observation is the significant predominance of the three predisposing polymorphic alleles among the adenocarcinoma patients (OR = 3.4, 95% CL = 0.78-16.1, P = 0.05) compared with the squamous cell carcinoma patients. The results of this study indicate that the inheritance of several polymorphic metabolizing genes, particularly the CYP2E1 gene, contributes not only to the development of lung cancer but also to the development of specific types of cancer.

Original languageEnglish (US)
Pages (from-to)71-78
Number of pages8
JournalCancer Letters
Volume112
Issue number1
DOIs
StatePublished - Jan 15 1997

Fingerprint

Cytochrome P-450 CYP2E1
Lung Neoplasms
Histology
Adenocarcinoma
Genes
Squamous Cell Carcinoma
Observation
Polymerase Chain Reaction
Genetic Predisposition to Disease
Gene Frequency
Tobacco Products
Restriction Fragment Length Polymorphisms
Neoplasms
Alleles
Genotype
Lymphocytes
Gene Expression
Mutation
DNA

Keywords

  • CYP2E1
  • Genes
  • Genetic polymorphism
  • GSTM1
  • GSTT1
  • Histology
  • Lung cancer
  • Molecular epidemiology
  • Smoking

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology

Cite this

Polymorphism of metabolizing genes and lung cancer histology : Prevalence of CYP2E1 in adenocarcinoma. / El-Zein, Randa A.; Zwischenberger, Joseph B.; Abdel-Rahman, Sherif; Sankar, Aravind B.; Au, William W.

In: Cancer Letters, Vol. 112, No. 1, 15.01.1997, p. 71-78.

Research output: Contribution to journalArticle

El-Zein, Randa A. ; Zwischenberger, Joseph B. ; Abdel-Rahman, Sherif ; Sankar, Aravind B. ; Au, William W. / Polymorphism of metabolizing genes and lung cancer histology : Prevalence of CYP2E1 in adenocarcinoma. In: Cancer Letters. 1997 ; Vol. 112, No. 1. pp. 71-78.
@article{f72f66a1b5af450b81c21213a7f180ee,
title = "Polymorphism of metabolizing genes and lung cancer histology: Prevalence of CYP2E1 in adenocarcinoma",
abstract = "The relationship between genetic predisposition and development of specific cancers has not been adequately elucidated. In this study, the involvement of three polymorphic genes (CYP2E1, GSTM1, and GSTT1) in the development of different histological types of lung cancer was investigated. DNA was extracted from peripheral blood lymphocytes of lung cancer patients who have been long-term cigarette smokers (n = 52). Allelic variants of CYP2E1 were detected using PCR followed by PstI restriction enzyme digest and RFLP analysis, which detects a specific mutation causing over-expression of the gene. GSTM1 and GSTT1 genotypes were detected using two separate differential PCR methods. Our results indicate a 13.5{\%} allele frequency for the CYP2E1 rare PstI site among the lung cancer patients which represents a 3.4-fold increase over the normal controls (OR = 3.5, 95{\%} CL = 0.65-25.8). A novel observation is that all the patients with this polymorphism had adenocarcinomas only, resulting in a significant association between them (OR = 16.17, 95{\%} CL = 0.95-73, P = 0.02). The frequency of the null GSTM1 gene was 42.3{\%} among the lung cancer patients with no preferential tendency towards developing squamous cell carcinoma versus adenocarcinoma (OR = 1.10, 95{\%} CL = 0.3-4.14, P = 0.5). The GSTT1 gene was absent in 21.1{\%} of the patients with a non-significant tendency towards developing squamous cell carcinoma (OR = 1.23, 95{\%} CL = 0.25-6.1, P = 0.5). Another important observation is the significant predominance of the three predisposing polymorphic alleles among the adenocarcinoma patients (OR = 3.4, 95{\%} CL = 0.78-16.1, P = 0.05) compared with the squamous cell carcinoma patients. The results of this study indicate that the inheritance of several polymorphic metabolizing genes, particularly the CYP2E1 gene, contributes not only to the development of lung cancer but also to the development of specific types of cancer.",
keywords = "CYP2E1, Genes, Genetic polymorphism, GSTM1, GSTT1, Histology, Lung cancer, Molecular epidemiology, Smoking",
author = "El-Zein, {Randa A.} and Zwischenberger, {Joseph B.} and Sherif Abdel-Rahman and Sankar, {Aravind B.} and Au, {William W.}",
year = "1997",
month = "1",
day = "15",
doi = "10.1016/S0304-3835(96)04547-8",
language = "English (US)",
volume = "112",
pages = "71--78",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Polymorphism of metabolizing genes and lung cancer histology

T2 - Prevalence of CYP2E1 in adenocarcinoma

AU - El-Zein, Randa A.

AU - Zwischenberger, Joseph B.

AU - Abdel-Rahman, Sherif

AU - Sankar, Aravind B.

AU - Au, William W.

PY - 1997/1/15

Y1 - 1997/1/15

N2 - The relationship between genetic predisposition and development of specific cancers has not been adequately elucidated. In this study, the involvement of three polymorphic genes (CYP2E1, GSTM1, and GSTT1) in the development of different histological types of lung cancer was investigated. DNA was extracted from peripheral blood lymphocytes of lung cancer patients who have been long-term cigarette smokers (n = 52). Allelic variants of CYP2E1 were detected using PCR followed by PstI restriction enzyme digest and RFLP analysis, which detects a specific mutation causing over-expression of the gene. GSTM1 and GSTT1 genotypes were detected using two separate differential PCR methods. Our results indicate a 13.5% allele frequency for the CYP2E1 rare PstI site among the lung cancer patients which represents a 3.4-fold increase over the normal controls (OR = 3.5, 95% CL = 0.65-25.8). A novel observation is that all the patients with this polymorphism had adenocarcinomas only, resulting in a significant association between them (OR = 16.17, 95% CL = 0.95-73, P = 0.02). The frequency of the null GSTM1 gene was 42.3% among the lung cancer patients with no preferential tendency towards developing squamous cell carcinoma versus adenocarcinoma (OR = 1.10, 95% CL = 0.3-4.14, P = 0.5). The GSTT1 gene was absent in 21.1% of the patients with a non-significant tendency towards developing squamous cell carcinoma (OR = 1.23, 95% CL = 0.25-6.1, P = 0.5). Another important observation is the significant predominance of the three predisposing polymorphic alleles among the adenocarcinoma patients (OR = 3.4, 95% CL = 0.78-16.1, P = 0.05) compared with the squamous cell carcinoma patients. The results of this study indicate that the inheritance of several polymorphic metabolizing genes, particularly the CYP2E1 gene, contributes not only to the development of lung cancer but also to the development of specific types of cancer.

AB - The relationship between genetic predisposition and development of specific cancers has not been adequately elucidated. In this study, the involvement of three polymorphic genes (CYP2E1, GSTM1, and GSTT1) in the development of different histological types of lung cancer was investigated. DNA was extracted from peripheral blood lymphocytes of lung cancer patients who have been long-term cigarette smokers (n = 52). Allelic variants of CYP2E1 were detected using PCR followed by PstI restriction enzyme digest and RFLP analysis, which detects a specific mutation causing over-expression of the gene. GSTM1 and GSTT1 genotypes were detected using two separate differential PCR methods. Our results indicate a 13.5% allele frequency for the CYP2E1 rare PstI site among the lung cancer patients which represents a 3.4-fold increase over the normal controls (OR = 3.5, 95% CL = 0.65-25.8). A novel observation is that all the patients with this polymorphism had adenocarcinomas only, resulting in a significant association between them (OR = 16.17, 95% CL = 0.95-73, P = 0.02). The frequency of the null GSTM1 gene was 42.3% among the lung cancer patients with no preferential tendency towards developing squamous cell carcinoma versus adenocarcinoma (OR = 1.10, 95% CL = 0.3-4.14, P = 0.5). The GSTT1 gene was absent in 21.1% of the patients with a non-significant tendency towards developing squamous cell carcinoma (OR = 1.23, 95% CL = 0.25-6.1, P = 0.5). Another important observation is the significant predominance of the three predisposing polymorphic alleles among the adenocarcinoma patients (OR = 3.4, 95% CL = 0.78-16.1, P = 0.05) compared with the squamous cell carcinoma patients. The results of this study indicate that the inheritance of several polymorphic metabolizing genes, particularly the CYP2E1 gene, contributes not only to the development of lung cancer but also to the development of specific types of cancer.

KW - CYP2E1

KW - Genes

KW - Genetic polymorphism

KW - GSTM1

KW - GSTT1

KW - Histology

KW - Lung cancer

KW - Molecular epidemiology

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=0031031785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031031785&partnerID=8YFLogxK

U2 - 10.1016/S0304-3835(96)04547-8

DO - 10.1016/S0304-3835(96)04547-8

M3 - Article

VL - 112

SP - 71

EP - 78

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -